The performer has never stated she uses the medication, and no credible medical disclosures or news outlets have produced evidence establishing its use
The drugs mimic GLP-1, a hormone the body produces after eating, which can decrease appetite and help the body manage insulin production
FDA: unapproved GLP-1 drug safety concerns Regulator Used for safety language around compounded, counterfeit, and unapproved GLP-1 products
What matters is the weekly cadence and the consistency of your overall protocol not whether you injected at 8 AM versus 11 AM on any single week
slow down gastric emptying, causing you to feel full longer after a healthy meal
Browne SK, Suschak JJ, Tomah S, et al